ABVC BioPharma (ABVC) SEC Filings & 10K Form $0.70 +0.11 (+19.59%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.69 -0.01 (-1.94%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Recent ABVC BioPharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView02/14/20254:13 PMABVC BioPharma (Subject)Lind Global Fund II LP (Filed by)Form SCHEDULE 13G/A11/15/20242:26 PMABVC BioPharma (Filer)Form 424B411/15/20242:28 PMABVC BioPharma (Filer)Form 424B411/15/20242:30 PMABVC BioPharma (Filer)Form 424B411/15/20242:31 PMABVC BioPharma (Filer)Form 424B411/14/20246:33 PMABVC BioPharma (Subject)Lind Global Fund II LP (Filed by)Form SC 13G/A11/14/20248:25 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/14/20247:30 AMABVC BioPharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/04/20244:00 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/25/202411:21 AMABVC BioPharma (Filer)Form 424B410/18/20244:23 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) Get the Latest News and Ratings for ABVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. 09/10/20243:01 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/20/20243:30 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/16/20243:30 PMABVC BioPharma (Filer)Form 424B408/16/20243:30 PMABVC BioPharma (Filer)Form 424B408/16/20243:31 PMABVC BioPharma (Filer)Form 424B408/15/20246:00 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20242:18 PMABVC BioPharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/07/20244:15 PMABVC BioPharma (Filer)Form 424B508/01/202411:15 PMABVC BioPharma (Filer)Form EFFECT07/26/20243:30 PMABVC BioPharma (Filer)Form POS AM07/23/20244:00 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/01/202411:15 PMABVC BioPharma (Filer)Form EFFECT06/25/20244:15 PMABVC BioPharma (Filer)Form 8-K/A06/24/20244:15 PMABVC BioPharma (Filer)Form 8-K/A06/21/20244:02 PMABVC BioPharma (Filer)Form S-1Registration statement under Securities Act of 1933 05/24/20247:00 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/23/20244:00 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/22/20241:31 PMABVC BioPharma (Filer)Form 424B405/15/20244:00 PMABVC BioPharma (Filer)Form NT 10-Q05/15/20248:00 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/09/20248:27 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/30/202411:15 PMABVC BioPharma (Filer)Form EFFECT04/25/20241:38 PMABVC BioPharma (Filer)Form POS AM04/19/20244:26 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/17/20247:30 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/05/20241:47 PMABVC BioPharma (Filer)Form 424B404/01/202411:15 PMABVC BioPharma (Filer)Form EFFECT03/26/20247:35 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/25/20243:30 PMABVC BioPharma (Filer)Form DEFA14A03/22/20244:01 PMABVC BioPharma (Filer)Form S-1/ACollect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.03/14/202411:08 AMABVC BioPharma (Filer)Form DEFA14A03/14/202410:33 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/14/20248:04 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/13/20244:14 PMABVC BioPharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/29/20243:32 PMABVC BioPharma (Filer)Form 8-K/A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies CTXR 10Q Form TRAW 10Q Form ENLV 10Q Form BCAB 10Q Form TNXP 10Q Form LSB 10Q Form MTEX 10Q Form SXTP 10Q Form NXTC 10Q Form INAB 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ABVC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.